Rebeprazole sodium enteric-coated tablets can treat gastric polyps accompanied by erosive gastritis, gastric ulcers and other comorbidities, but can not completely treat gastric polyps. Patients should use the medicine reasonably under the guidance of the doctor. Gastric polyp is a protruding papillary tissue that grows on the surface of the gastric mucosa, generally no clinical symptoms in the early stages or complications, symptoms often manifested as epigastric pain, abdominal distension, discomfort, nausea, vomiting and so on. The treatment of choice for gastric polyps is endoscopic resection. Most gastric polyps are associated with comorbidities such as erosive gastritis and gastric ulcers, and the use of proton pump inhibitors is recommended for adjuvant treatment. Rabeprazole sodium enteric-coated tablets is a proton pump inhibitor, mainly used for the treatment of gastric ulcers, duodenal ulcers, anastomotic ulcers, reflux esophagitis, Zuo-Ai syndrome and so on. Adverse reactions to rabeprazole sodium enteric coated tablets include allergic reaction or shock, pancytopenia, thrombocytopenia, granulocyte deficiency, hemolytic anemia, constipation, diarrhea, abdominal distension, nausea, lower abdominal pain, dyspepsia, hepatic injury, headache, vertigo, drowsiness, weakness of the limbs, dullness of sensation, slurred speech, hobbling gait, and swelling, among other symptoms. In addition, patients who are allergic to the ingredients contained in rabeprazole sodium enteric-coated tablets are prohibited, hepatic dysfunction and elderly patients should be used with caution, pregnant women need to weigh the pros and cons of the use of lactating women should avoid the use of children’s drug safety is not clear. If you need to use rabeprazole sodium enteric-coated tablets or the treatment of gastric polyps, it is recommended to consult a professional doctor, follow the doctor’s instructions to standardize the treatment, can not blindly use their own medication.